The S&P Kensho Human Evolution Index is designed to measure the performance of companies involved in genetic engineering; those producing human-capability enhancement products like wearables and virtual reality companies; nanotechnology and robotics companies that focus on the medical, surgical, nano-, and microbots; and 3D printing technologies for medical purposes.

A sector index within the S&P Kensho New Economy Index Series, the S&P Kensho Human Evolution Index intends to represent companies in the S&P Kensho Genetic Engineering Index, the companies producing human-capability enhancement products or services in S&P Kensho Wearables Index and S&P Kensho Virtual Reality Index, the medical, surgical, nano- and microbots components from the S&P Kensho Nanotechnology Index and the S&P Kensho Robotics Index, and 3D printing technologies for medical purposes from the S&P Kensho 3D Printing Index. From fundamentally altering our genetic makeup to advanced wearable augmented reality (AR) devices that augment sensory capabilities and implantable medical devices that can directly affect an individual's physical condition, the human evolution industry is at the cutting edge of technological research and development.